Moustafa, Ahmed
AbdAllah, Mohamed
Akel, Wafaa El
Wahed, Sherif
Alem, Shereen Abdel https://orcid.org/0000-0002-3612-0130
Esmat, Gamal
Article History
Received: 9 June 2024
Accepted: 2 September 2024
First Online: 9 September 2024
Declarations
:
: The study was performed in accordance with the principles of Good Clinical Practice (GCP) and the Declaration of Helsinki and it was approved by the Institutional Review Board (IRB) of the Faculty of Medicine, Cairo University (N-120–2020). All patients provided their written informed consent to participate in this study before receiving HCV treatment.
: Not applicable.
: Gamal Esmat: speaker, advisory board member and investigator for Gilead Science while all other authors: nothing to be declared.